loadpatents
Patent applications and USPTO patent grants for ZHANG; Yongke.The latest application filed is for "anti-cd40 antibodies and methods of use".
Patent | Date |
---|---|
Anti-cd40 Antibodies And Methods Of Use App 20220049006 - ZHANG; Yongke ;   et al. | 2022-02-17 |
Anti-cd40 Antibodies And Methods Of Use App 20220049005 - ZHANG; Yongke ;   et al. | 2022-02-17 |
Anti-CD40 antibodies Grant 11,001,637 - Zhang , et al. May 11, 2 | 2021-05-11 |
Cd19-cd20 Bispecific And Dual Passway Car-t And Methods For Use Thereof App 20210079111 - Zhang; Yongke ;   et al. | 2021-03-18 |
Multi-function And Multi-targeting Car System And Methods For Use Thereof App 20200038443 - Zhang; Yongke ;   et al. | 2020-02-06 |
Anti-rankl Antibodies And Methods Of Use App 20190309080 - Zhang; Yongke ;   et al. | 2019-10-10 |
Anti-RANKL antibodies and methods of use Grant 10,259,878 - Zhang , et al. | 2019-04-16 |
Anti-cd40 Antibodies And Methods Of Use App 20180273630 - ZHANG; Yongke ;   et al. | 2018-09-27 |
Anti-CD40 antibodies Grant 9,994,640 - Zhang , et al. June 12, 2 | 2018-06-12 |
Anti-IL-6 receptor antibodies and methods of use Grant 9,951,136 - Lee , et al. April 24, 2 | 2018-04-24 |
Anti-cd40 Antibodies And Methods Of Use App 20170246297 - Zhang; Yongke ;   et al. | 2017-08-31 |
Anti-cd40 Antibodies And Methods Of Use App 20170233483 - ZHANG; Yongke ;   et al. | 2017-08-17 |
Anti-CD40 antibodies and methods of use Grant 9,676,861 - Zhang , et al. June 13, 2 | 2017-06-13 |
Anti-CD40 antibodies Grant 9,556,278 - Zhang , et al. January 31, 2 | 2017-01-31 |
Anti-KDR antibodies and methods of use Grant 9,441,042 - Ke , et al. September 13, 2 | 2016-09-13 |
Anti-cd40 Antibodies And Methods Of Use App 20160208007 - ZHANG; Yongke ;   et al. | 2016-07-21 |
Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD40 antibodies Grant 9,266,956 - Zhang , et al. February 23, 2 | 2016-02-23 |
Anti-rankl Antibodies And Methods Of Use App 20160032001 - Zhang; Yongke ;   et al. | 2016-02-04 |
Anti-cd40 Antibodies And Methods Of Use App 20150307616 - ZHANG; Yongke ;   et al. | 2015-10-29 |
Anti-IL-1.beta. antibodies Grant 9,085,621 - Ke , et al. July 21, 2 | 2015-07-21 |
Humanized anti-CD20 monoclonal antibody Grant 9,045,543 - Liu , et al. June 2, 2 | 2015-06-02 |
Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody Grant 8,986,692 - Li , et al. March 24, 2 | 2015-03-24 |
Polynucleotides encoding anti-CD40 antibodies Grant 8,957,193 - Zhang , et al. February 17, 2 | 2015-02-17 |
Anti-kdr Antibodies And Methods Of Use App 20140377282 - Ke; Yaohuang ;   et al. | 2014-12-25 |
Anti-cd40 Antibodies And Methods Of Use App 20140349395 - ZHANG; Yongke ;   et al. | 2014-11-27 |
Anti-il-6 Receptor Antibodies And Methods Of Use App 20140322239 - Lee; Sum Wai Pierre ;   et al. | 2014-10-30 |
Anti-CD40 antibodies Grant 8,778,345 - Zhang , et al. July 15, 2 | 2014-07-15 |
Anti-IL-6 receptor antibodies and methods of use Grant 8,753,634 - Lee , et al. June 17, 2 | 2014-06-17 |
Anti-cd40 Antibodies And Methods Of Use App 20140120103 - Zhang; Yongke ;   et al. | 2014-05-01 |
Anti-il-1beta Antibodies And Methods Of Use App 20130330355 - Ke; Yaohuang ;   et al. | 2013-12-12 |
New Humanized Anti-CD20 Monoclonal Antibody App 20130089540 - Liu; Jie ;   et al. | 2013-04-11 |
Anti-cd40 Antibodies And Methods Of Use App 20120301488 - Zhang; Yongke ;   et al. | 2012-11-29 |
Anti-vegf Monoclonal Antibody And Pharmaceutical Composition Comprising Said Antibody App 20120231011 - Li; Pierre ;   et al. | 2012-09-13 |
Anti-il-6 Receptor Antibodies And Methods Of Use App 20120225060 - Lee; Sum Wai Pierre ;   et al. | 2012-09-06 |
Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer App 20080260740 - ZHANG; Yongke ;   et al. | 2008-10-23 |
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer Grant 7,399,469 - Zhang , et al. July 15, 2 | 2008-07-15 |
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer App 20050260212 - Zhang, Yongke ;   et al. | 2005-11-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.